{
    "clinical_study": {
        "@rank": "159911", 
        "arm_group": [
            {
                "arm_group_label": "Standard Dose online HDF", 
                "arm_group_type": "Active Comparator", 
                "description": "Proposed target convection volume; 16.8-21.5 L/treatment (70-90 mL/min)"
            }, 
            {
                "arm_group_label": "High Dose online HDF", 
                "arm_group_type": "Experimental", 
                "description": "Proposed target convection volume; 33-43 L/treatment (140-180 mL/min)."
            }
        ], 
        "brief_summary": {
            "textblock": "Online hemodiafiltration (HDF) may improve clinical outcome in end-stage renal disease. The\n      supported mechanism is the improved clearance of uremic toxins by convective transporter.\n      However, It has not been elucidated which convection volume is optimal, especially in Asia.\n      A total of 60 participants receiving conventional hemodialysis will be randomly assigned to\n      receive either high dose convective volume (33-43 L/treatment) post-dilution online HDF or\n      standard dose (16.8-21.5 L/treatment) for 24 weeks. The primary outcome is the change of\n      serum \u03b22 microglobulin levels between baseline and after 24 weeks. The secondary outcomes\n      will include changes in the nutritional markers, inflammatory markers, and blood pressure\n      from baseline to after treatment.\n\n      This would be the first multicenter prospective, randomized controlled trial to determine\n      whether large convective volume improves the treatment efficacy in Korean patients\n      undergoing post-dilution online HDF."
        }, 
        "brief_title": "High Versus Standard Volume Hemodiafiltration in Asia", 
        "completion_date": {
            "#text": "December 2016", 
            "@type": "Anticipated"
        }, 
        "condition": "End-stage Renal Disease", 
        "condition_browse": {
            "mesh_term": [
                "Kidney Diseases", 
                "Kidney Failure, Chronic"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Patients on thrice-weekly standard hemodialysis for > 3 months\n\n          -  Patients with a vascular access capable of delivering consistently a high blood flow\n             rates ( \u2265 300 mL/min)\n\n          -  Patients willing to provide written informed consent.\n\n        Exclusion Criteria:\n\n          -  Patients with active infectious or uncontrolled inflammatory disorders\n\n          -  Patients with any uncontrolled malignant disease\n\n          -  Patients with recent major cardiovascular disease during the last 6 months\n\n          -  Patients who are likely to receive kidney transplant within the following 1 year\n\n          -  Patients whose life expectancy < 12 months\n\n          -  Patients considered by investigator to have difficulty in participation"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "75 Years", 
            "minimum_age": "20 Years"
        }, 
        "enrollment": {
            "#text": "60", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "March 17, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02092194", 
            "org_study_id": "KHSG-201301"
        }, 
        "intervention": [
            {
                "arm_group_label": "High Dose online HDF", 
                "description": "Convection volume; 33-43 L/treatment (140-180 mL/min)", 
                "intervention_name": "High Dose Online HDF", 
                "intervention_type": "Procedure", 
                "other_name": "High Volume online hemodiafiltration"
            }, 
            {
                "arm_group_label": "Standard Dose online HDF", 
                "description": "convection volume; 16.8-21.5 L/treatment (70-90 mL/min)", 
                "intervention_name": "Standard Dose Online HDF", 
                "intervention_type": "Procedure", 
                "other_name": "Standard Volume online hemodiafiltration"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "beta 2-Microglobulin", 
            "Hemodiafiltration", 
            "convective volume"
        ], 
        "lastchanged_date": "March 19, 2014", 
        "location": [
            {
                "contact": {
                    "email": "imnksk@gmail.com", 
                    "last_name": "Sung Gyun Kim, MD", 
                    "phone": "+82-31-380-3976"
                }, 
                "contact_backup": {
                    "email": "dongangagy@lycos.co.kr", 
                    "last_name": "Soo Jin Kim, MD", 
                    "phone": "+82-10-8722-8078"
                }, 
                "facility": {
                    "address": {
                        "city": "Anyang", 
                        "country": "Korea, Republic of", 
                        "state": "Gyeonggi-do"
                    }, 
                    "name": "Hallym University Sacred Heart Hospital"
                }, 
                "investigator": [
                    {
                        "last_name": "Sung Gyun Kim, MD", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "Soo Jin Kim, MD", 
                        "role": "Sub-Investigator"
                    }
                ], 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "sh76so@cau.ac.kr", 
                    "last_name": "Su-Hyun Kim, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Seoul", 
                        "country": "Korea, Republic of"
                    }, 
                    "name": "Chung-Ang University Hospital"
                }, 
                "investigator": {
                    "last_name": "Su-Hyun Kim, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "amp97@yuhs.ac", 
                    "last_name": "Hyeong Cheon Park, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Seoul", 
                        "country": "Korea, Republic of"
                    }, 
                    "name": "Yonsei University Gangnam Severance Hospital"
                }, 
                "investigator": {
                    "last_name": "Hyeong Cheon Park, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "wonyong@korea.ac.kr", 
                    "last_name": "Won-Yong Cho, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Seoul", 
                        "country": "Korea, Republic of"
                    }, 
                    "name": "Korea University Anam Hospital"
                }, 
                "investigator": {
                    "last_name": "Won-Yong Cho, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "ryounge@hanmail.net", 
                    "last_name": "Sun Ryoung Choi, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Seoul", 
                        "country": "Korea, Republic of"
                    }, 
                    "name": "Shamyook Medical Center"
                }, 
                "investigator": {
                    "last_name": "Sun-Ryoung Choi, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "junephro@snu.ac.kr", 
                    "last_name": "Kwon Wook Joo, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Seoul", 
                        "country": "Korea, Republic of"
                    }, 
                    "name": "Seoul National University Hospital"
                }, 
                "investigator": {
                    "last_name": "Kwon Wook Joo, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }
        ], 
        "location_countries": {
            "country": "Korea, Republic of"
        }, 
        "number_of_arms": "2", 
        "official_title": "Effectiveness of High-volume Online Hemodiafiltration Compared to Standard Volume Online Hemodiafiltration. A Prospective, Multicenter, Randomized, Open-labelled Interventional Study.", 
        "overall_contact": {
            "email": "imnksk@gmail.com", 
            "last_name": "Sung Gyun Kim, MD", 
            "phone": "+82-10-3586-8561"
        }, 
        "overall_contact_backup": {
            "email": "dongangagy@lycos.co.kr", 
            "last_name": "Soo Jin Kim, MD", 
            "phone": "+82-10-8722-8078"
        }, 
        "overall_official": {
            "affiliation": "Korea University", 
            "last_name": "Won-Yong Cho, MD", 
            "role": "Study Director"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "South Korea: Korea Food and Drug Administration (KFDA)", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "March 2016", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "changes in the serum concentration of \u03b22 microglobulin", 
            "safety_issue": "No", 
            "time_frame": "between baseline and 24 weeks after treatment"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02092194"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Korean Hemodialysis Study Group", 
            "investigator_full_name": "Sung Gyun Kim", 
            "investigator_title": "Professor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "Kt/V by the single pool variable volume formula.", 
                "measure": "Dialysis Adequacy", 
                "safety_issue": "No", 
                "time_frame": "24 weeks"
            }, 
            {
                "description": "C-reactive protein (CRP), interleukin-6, tumor necrosis factor-\u03b1.", 
                "measure": "Inflammatory markers", 
                "safety_issue": "No", 
                "time_frame": "24 weeks"
            }, 
            {
                "description": "normalized protein nitrogen appearance rate, serum albumin, serum protein, subjective global assessment (SGA)", 
                "measure": "Nutritional status", 
                "safety_issue": "No", 
                "time_frame": "24 weeks"
            }, 
            {
                "description": "Number of episode of symptomatic hypotension", 
                "measure": "Intradialytic hypotension", 
                "safety_issue": "Yes", 
                "time_frame": "24 weeks"
            }, 
            {
                "description": "SF-36-K (Korean version)", 
                "measure": "Quality of Life", 
                "safety_issue": "No", 
                "time_frame": "baseline and 24 weeks after treatment"
            }
        ], 
        "source": "Korean Hemodialysis Study Group", 
        "sponsors": {
            "collaborator": {
                "agency": "Boryung Pharmaceutical Co., Ltd", 
                "agency_class": "Industry"
            }, 
            "lead_sponsor": {
                "agency": "Korean Hemodialysis Study Group", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "April 2014", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "March 2014"
    }
}